Events2Join

Planning Decentralized Trials


Defining Decentralized Clinical Trials and Understanding Their ...

The same holds true in planning for clinical trials. Clarity – through consistency – in the regulatory landscape post-COVID-19 will go a long ...

Decentralized Clinical Trials: A Much-Needed Plan for a More ...

Most businesses are managing their clients' information via decentralized platforms. It would be to the benefit of clinical research ...

Decentralized Trials - Hybrid & Virtual Trials Solution - IQVIA

IQVIA™ Decentralized Trials bring studies directly to patients, increasing participation and boosting research and development cycle times.

Decentralized and Digital Clinical Trials - PPD

Choosing decentralized clinical trials. As the clinical landscape continues to evolve, the use of DCT solutions increases, keeping research moving forward and ...

Back to Basics: What is a decentralized clinical trial? | Medable

Project managers help study teams accurately predict country-specific needs and tailor distribution plans to ensure the right supplies are ...

Everything You Need to Know About the Advent of Decentralized ...

Stay ahead in clinical research with decentralized trials. See how ... plan decentralized trials better. Navigating the wide range of ...

Decentralized Clinical Trials - Capabilities and Solutions - PPD

Our DCT ecosystem optimizes decentralized clinical trials. The goal of the PPD™ clinical research business of Thermo Fisher Scientific has always been to ...

Decentralized Clinical Trials | What the Future Holds

But the COVID crisis forced research operations leaders to accelerate their plans for remote and hybrid trials. Decentralized clinical ...

FAQs to Guide Your Decentralized Clinical Trials Strategy | Medidata

What are decentralized trials? What impacts can trial decentralization have on sites and patients? Decentralized trials, also known ...

You Need a Decentralized Clinical Trials Strategy Before a Disaster

Some sites had a back-up plan, others needed full support, so DCT providers were forced to accommodate multiple approaches. While the overall ...

Priorities and Initiatives - Decentralized Trials & Research Alliance

Explore the end-to-end process of decentralized clinical trials and learn about the key milestones that are integral to successful planning and execution.

Hybrid & Decentralized Trials | Advanced Clinical

While decentralized clinical trials (DCTs) and hybrid clinical trials have been ... planning accurately in accordance with your study goals. Our global ...

Decentralized Clinical Trials - MED Institute

A monitoring plan should be tailored to the unique considerations of a DCT. For example, centralized monitoring can aid in detecting systemic ...

Decentralized Clinical Trial Technologies - Citeline

Technology is the backbone of decentralized clinical trials (DCTs), for both investigators and patients.

Decentralized Clinical Trials: An Overview - VWR International

Stages of a decentralized clinical trial · Study Planning and Protocol Development · Participant Recruitment and Screening · Informed Consent and Enrollment · Data ...

The Rise of Decentralized Clinical Trials - Veristat

Clinical trial planning & design is highly complex and requires a team of statistical, safety, and scientific experts. At Veristat, our team gets clinical ...

Decentralized Clinical Trials | Virtual Trial Solutions - Fortrea

Fortrea's decentralized clinical trial (DCT) solutions offer a host of remote, mobile and virtual capabilities, which set a new standard for how trials ...

Decentralized Clinical Trials, Part 1 – Its History (and Future?)

Delve into the evolution of Decentralized Clinical Trials (DCT), from early implementations to current practices and future potential, ...

What are Decentralized Clinical Trials? - Vial

In the world of clinical research, decentralization is becoming more and more common. As a result, we're seeing more decentralized clinical trials—or ...

Decentralized & Hybrid | SCOPE Summit | February 3-6, 2025

What are key considerations for clinical trial planning, site selection, and protocol design? And, what and why did Merck keep many core capabilities “in-house” ...